188 related articles for article (PubMed ID: 335742)
1. [Use of hybrid strains of S, typhi and S. typhimurium for characterizing the biological activity of individual Salmonella antigens by the alternative recording of the experimental results].
Levina LA; Zaĭdner IG
Zh Mikrobiol Epidemiol Immunobiol; 1977 Aug; (8):31-6. PubMed ID: 335742
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.
Johnson EM; Diena BB; Lior H; Ryan A; Krol P; Baron LS
Infect Immun; 1982 Oct; 38(1):201-5. PubMed ID: 6754614
[TBL] [Abstract][Full Text] [Related]
3. Role of typhoid antigens in protection and pathogenicity for mice.
Diena BB; Baron LS; Johnson EM; Wallace R; Ashton FE
Infect Immun; 1974 Jun; 9(6):1102-4. PubMed ID: 4598256
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of parenteral and oral typhoid vaccination in mice challenged with a Salmonella typhi-Salmonella typhimurium hybrid.
Diena BB; Ryan A; Wallace R; Johnson EM; Baron LS; Ashton FE
Infect Immun; 1977 Mar; 15(3):997-8. PubMed ID: 67085
[TBL] [Abstract][Full Text] [Related]
5. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
6. [Protective role of Salmonella R mutants in Salmonella infection in mice (author's transl)].
Schlecht S; Westphal O
Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):71-88. PubMed ID: 44625
[TBL] [Abstract][Full Text] [Related]
7. Assay of typhoid vaccines with Salmonella typhosa-Salmonella typhimurium hybrids.
Diena BB; Johnson EM; Baron LS; Wallace R; Greenberg L
Infect Immun; 1973 Jan; 7(1):5-8. PubMed ID: 4120357
[TBL] [Abstract][Full Text] [Related]
8. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
[TBL] [Abstract][Full Text] [Related]
9. Ineffectiveness of Vi and chemically treated endotoxins as typhoid vaccines in mice challenged with a Salmonella typhosa-Salmonella typhimurium hybrid.
Diena BB; Ryan A; Wallace R; Ashton FE; Johnson EM; Baron LS
Infect Immun; 1975 Dec; 12(6):1470-1. PubMed ID: 1107227
[TBL] [Abstract][Full Text] [Related]
10. Studies on infection and immunity in experimental typhoid fever. III. Effect of prophylactic immunization.
GAINES S; LANDY M; EDSALL G; MANDEL AD; TRAPANI RJ; BENENSON AS
J Exp Med; 1961 Sep; 114(3):327-42. PubMed ID: 13702952
[TBL] [Abstract][Full Text] [Related]
11. rIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium.
Kaur G; STS C; Nimker C; Bansal A
Cell Mol Immunol; 2015 Jan; 12(1):96-106. PubMed ID: 24858422
[TBL] [Abstract][Full Text] [Related]
12. [Antigenic structure of Salmonella L forms studied by an immunoferritin method].
Prozorovskiĭ SV; Kirillova FM; Stepanova LK; Gorelov AL; Levina GA
Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):24-6. PubMed ID: 2409718
[TBL] [Abstract][Full Text] [Related]
13. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.
Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA
Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548
[TBL] [Abstract][Full Text] [Related]
14. [Production of humoral antibodies to salmonella Vi-, H- I and O-antigens in mice preliminarily treated with a cytoplasmic fraction from E. coli].
Stanislavskiĭ ES; Kirpatovskiĭ ID; Levina LA; Bogdanova VV; Eltonskaia GA
Zh Mikrobiol Epidemiol Immunobiol; 1974 Feb; (2):123-8. PubMed ID: 4616561
[No Abstract] [Full Text] [Related]
15. Mouse protective capabilities of Escherichia coli hybrids expressing Salmonella typhi antigens.
Diena BB; Lior H; Ryan A; Krol P; Johnson EM; Baron LS
Infect Immun; 1979 Apr; 24(1):90-3. PubMed ID: 378849
[TBL] [Abstract][Full Text] [Related]
16. Protection against Salmonella typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella typhi 9,12,d, Vi.
Isibasi A; Ortiz V; Vargas M; Paniagua J; González C; Moreno J; Kumate J
Infect Immun; 1988 Nov; 56(11):2953-9. PubMed ID: 2844676
[TBL] [Abstract][Full Text] [Related]
17. Experimental study of vaccines against Salmonella typhimurium infection.
Severtsova MK; Stanislavsky ES; El'-Bashir AM; Zaidner IG
J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):318-25. PubMed ID: 393775
[TBL] [Abstract][Full Text] [Related]
18. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
19. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
Robbins JD; Robbins JB
J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249
[TBL] [Abstract][Full Text] [Related]
20. Cellular aspects of the longer-lasting immunity against mouse typhoid infection afforded by the live-cell and ribosomal vaccines.
Kita E; Emoto M; Yasui K; Yasui K; Katsui N; Nishi K; Kashiba S
Immunology; 1986 Mar; 57(3):431-5. PubMed ID: 3514442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
